Feasibility Study and Practical Applications Using Independent Core Observer Model AGI Systems for Behavioral Modification in Recalcitrant Populations

  • David KelleyEmail author
  • Mark Waser
Conference paper
Part of the Advances in Intelligent Systems and Computing book series (AISC, volume 848)


This paper articulates the results of a feasibility study and potential impact of the theoretical usage and application of an Independent Core Observer Model (ICOM) based Artificial General Intelligence (AGI) system and demonstrates the basis for why similar systems are well adapted to manage soft behaviors and judgements, in place of human judgement, ensuring compliance in recalcitrant populations. Such ICOM-based systems may prove able to enforce safer standards, ethical behaviors and moral thinking in human populations where behavioral modifications are desired. This preliminary research shows that such a system is not just possible but has a lot of far-reaching implications, including actually working. This study shows that this is feasible and could be done and would work from a strictly medical standpoint. Details around implementation, management and control on an individual basis make this approach an easy initial application of ICOM based systems in human populations; as well as introduce certain considerations, including severe ethical concerns.


AGI ICOM Feasibility Ethics 


  1. 1.
  2. 2.
    Kelley, D., Waser, M.: Human-like emotional responses in a simplified independent core observer model system. In: BICA 2017 Proceedings, Procedia Computer Science.
  3. 3.
    Waser, M., Kelley, D.: Architecting a human-like emotion-driven conscious moral mind for value alignment and AGI Safety. AGI Lab, Provo Utah—Pending Peer review; AI and Society: Ethics, Safety and Trustworthiness in Intelligent Agents—Stanford University, Palo Alto, CA, 26–28 March.
  4. 4.
    Lee, N, Kelley D.: The intelligence value argument and effects on regulating autonomous artificial intelligence. Chapter Inclusion in Book by Springer to be published 20917—Title Un-announced.
  5. 5.
    Bostrom, N.; Ethical issues in advanced artificial intelligence. In: Smit, I. et al. (eds.) Cognitive, Emotive and Ethical Aspects of Decision Making in Humans and in Artificial Intelligence, vol. 2, pp. 12–17. Institute of Advanced Studies in Systems Research and Cybernetics (2003).
  6. 6.
    Kelley, D.: The independent core observer model theory of consciousness and the mathematical model for subjective experience. In: The 2018 International Conference on Information Science and Technology, Passed Peer Review, IST 2018, China, 20–22 April 2018.
  7. 7.
    Umbrello, S.; Frank De Bellis, A.: A value-sensitive design approach to intelligent agents. In: Yampolskiy, R. (ed.) Artificial Intelligence Safety and Security. CRC Press (2018, Forthcoming).
  8. 8.
    APBA: Identifying Applied Behavior Analysis Interventions; Association of Professional Behavior Analysts (APBA) 2016–2017.
  9. 9.
    OPTUM: Modeling Behavior Change for Better Health. Resource Center for Health and Well-being.
  10. 10.
    Winters, S., Cox, E.: Behavior Modification Techniques for the Special Educator. ISBN: 084225000XGoogle Scholar
  11. 11.
    O’Neil, C.: Weapons of Math Destruction. Crown New York (2016)Google Scholar
  12. 12.
    Barrat, J.: Our Final Invention—Artificial Intelligence and the End of the Human Era; Thomas Dunne Books (2013)Google Scholar
  13. 13.
    Yampolskiy, R.: Artificial Superintelligence: A Futuristic Approach. CRC Press, Taylor & Francis Group (2016)Google Scholar
  14. 14.
    Barrett, L.: How Emotions Are Made—The Secret Life of the Brain. Houghton Mifflin Harcourt—Boston New York (2017)Google Scholar
  15. 15.
    Bresolin, L.: Aversion therapy. JAMA 258(18), 2562–2566 (1987). Scholar
  16. 16.
    Iwata, B.A.: The development and adoption of controversial default technologies. Behav. Anal. 11(2), 149–157 (1988)Google Scholar
  17. 17.
    Spreat, S., Lipinski, D., Dickerson, R., Nass, R., Dorsey, M.: The acceptability of electric shock programs. Behav. Modif. 13(2), 245–256 (1989). Scholar
  18. 18.
    Duker, P.C., Douwenga, H., Joosten, S., Franken, T.: Effects of single and repeated shock on perceived pain and startle response in healthy volunteers. Psychology Laboratory, University of Nijmegen and Plurijn Foundation, Netherlands.
  19. 19.
  20. 20.
    Israel, M., Blenkush, N., von Heyn, R., Rivera, P.: Treatment of Aggression with Behavioral Programming that includes Supplementary Contingent Skin-Shock. JOBA-OVTP 1(4) (2008)Google Scholar
  21. 21.
    Israel, M.: Behavioral Skin Shock Saves Individuals with Severe Behavior Disorders from a Life of Seclusion, Restraint and/or warehousing as well as the Ravages of Psychotropic Medication: Reply to the MDRI Appeal to the U.N. Special Rapporteur of Torture (2010)Google Scholar
  22. 22.
    Jordan, R.: Interview 4/7/2018; Provo, UTGoogle Scholar
  23. 23.
    Simeonov, A.: Drug delivery via remote control: the first clinical trial of an implantable microchip-based delivery device produces very encouraging results. Genetic Engineering and Biotechnology News (2012).
  24. 24.
    Mesquita, B., Smith, A.: The Dictator’s Handbook: Why Bad Behavior is Almost Always Good Politics. Public Affairs (2012). ISBN: 1610391845Google Scholar
  25. 25.
    Tegmark, M.: Life 3.0—Being Human in the Age of Artificial Intelligence. Knopf, Penguin Random House (2017). ISBN: 9781101946596Google Scholar
  26. 26.
    Guiard, B., Mansari, M., Merali, Z, Blier, P.: Functional Interactions between dopamine, serotonin and norepinephrine neurons: an in-vivo electrophysiological study in rats with monoaminergic lesions. IJON 11(5), 1 August 2008.
  27. 27.
    Hashemi, P., Dandoski, E., Lama, R., Wood, K., Takmakov, P., Wightman, R.: Brain dopamine and serotonin differ in regulation and its consequences. PNAS 109(29), 11510–11515 (2012). Scholar
  28. 28.
    Hagino, Y., Takamatsu, Y., Yamamoto, H., Iwamura, T., Murphy, D., Uhl, G., Sora, I., Ikeda, K.: Effects of MDMA on extracellular dopamine and serotonin levels in mice lacking dopamine and/or serotonin transporters. Curr. Neuropharmacol. 9(1), 91–95 (2011). Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Artificial General Intelligence Inc.ProvoUSA

Personalised recommendations